GAD1 and depressive symptom measurement: These findings indicate that addressing PHQ8 and PHQ2 in depression may reduce the risk of progression to loneliness and anxiety, while targeting GAD5 and GAD1 in anxiety may help prevent progression to loneliness and depression.